STING1 and neoplasm: Previous studies, using conditional whole‐body STING KO mice or STING activation by intratumoral injection of agonists, proposed that vascular STING expression and Type I IFNs promote anti‐tumor immunity (Demaria et al, 2015; Yang et al, 2019).